Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes

被引:71
作者
Bischof, MG [1 ]
Krssak, M [1 ]
Krebs, M [1 ]
Bernroider, E [1 ]
Stingl, H [1 ]
Waldhäusl, W [1 ]
Roden, M [1 ]
机构
[1] Univ Vienna, Sch Med, Dept Internal Med 3, Div Endocrinol & Metab, A-1090 Vienna, Austria
关键词
D O I
10.2337/diabetes.50.2.392
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insufficiently treated type 1 diabetic patients exhibit inappropriate postprandial hyperglycemia and reduction in liver glycogen stores. To examine the effect of acute improvement of metabolic control on hepatic glycogen metabolism, lean young type 1 diabetic (HbA(1c) 8.8 +/- 0.3%) and matched nondiabetic subjects (HbA(1c) 5.4 +/- 0.1%) were studied during the course of a day with three isocaloric mixed meals. Hepatic glycogen concentrations were determined noninvasively using in vivo C-13 nuclear magnetic resonance spectroscopy. Rates of net glycogen synthesis and breakdown mere calculated from linear regression of the glycogen concentration time curves from 7:30-10:30 P.M. and from 10:30 P.M. to 8:00 A.M., respectively. The mean plasma glucose concentration was similar to2.4-fold higher in diabetic than in nondiabetic subjects (13.6 +/- 0.4 vs. 5.8 +/- 0.1 mmol/l, P < 0.001). Rates of net glycogen synthesis and net glycogen breakdown were reduced by <similar to>74% (0.11 +/- 0.02 vs. 0.43 +/- 0.04 mmol/l liver/min, P < 0.001) and by <similar to>47% (0.10 +/- 0.01 vs. 0.19 +/- 0.01 mmol/l liver/min, P < 0.001) in diabetic patients, respectively. During short-term (24-h) intensified insulin treatment, the mean plasma glucose level was not different between diabetic and nondiabetic subjects (6.4 +/- 0.1 mmol/l). Net glycogen synthesis and breakdown increased by <similar to>92% (0.23 +/- 0.04 mmol/l liver/min, P = 0.017) and by similar to 40% (0.14 +/- 0.01 mmol/l liver/min, P = 0.011), respectively. In conclusion, poorly controlled type 1 diabetic patients present with marked reduction in both hepatic glycogen synthesis and breakdown. Both defects in glycogen metabolism are improved but not normalized by short-term restoration of insulinemia and glycemia.
引用
收藏
页码:392 / 398
页数:7
相关论文
共 52 条
[1]   LONG-TERM INTERMITTENT INTRAVENOUS INSULIN THERAPY AND TYPE-1 DIABETES-MELLITUS [J].
AOKI, TT ;
BENBARKA, MM ;
OKIMURA, MC ;
ARCANGELI, MA ;
WALTER, RM ;
WILSON, LD ;
TRUONG, MP ;
BARBER, AR ;
KUMAGAI, LF .
LANCET, 1993, 342 (8870) :515-518
[2]  
BARZILAI N, 1993, J BIOL CHEM, V268, P25019
[3]   Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism - Evidence for a defect in haptic glucokinase activity [J].
Basu, A ;
Basu, R ;
Shah, P ;
Vella, A ;
Johnson, CM ;
Nair, KS ;
Jensen, MD ;
Schwenk, WF ;
Rizza, RA .
DIABETES, 2000, 49 (02) :272-283
[4]   PORTAL AND PERIPHERAL VEIN IMMUNOREACTIVE INSULIN CONCENTRATIONS BEFORE AND AFTER GLUCOSE INFUSION [J].
BLACKARD, WG ;
NELSON, NC .
DIABETES, 1970, 19 (05) :302-&
[5]  
Bolli CB, 1999, DIABETES CARE, V22, pB43
[6]   THE EFFECT OF GROWTH-HORMONE ON SPLANCHNIC GLUCOSE AND SUBSTRATE METABOLISM FOLLOWING ORAL GLUCOSE LOADING IN HEALTHY MAN [J].
BRATUSCHMARRAIN, PR ;
GASIC, S ;
WALDHAUSL, WK ;
NOWOTNY, P .
DIABETES, 1984, 33 (01) :19-25
[7]   INSULIN REGULATION OF RENAL GLUCOSE-METABOLISM IN CONSCIOUS DOGS [J].
CERSOSIMO, E ;
JUDD, RL ;
MILES, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2584-2589
[8]   DIFFERENTIAL TIME COURSE OF GLUCAGONS EFFECT ON GLYCOGENOLYSIS AND GLUCONEOGENESIS IN THE CONSCIOUS DOG [J].
CHERRINGTON, AD ;
WILLIAMS, PE ;
SHULMAN, GI ;
LACY, WW .
DIABETES, 1981, 30 (03) :180-187
[9]   The direct and indirect effects of insulin on hepatic glucose production in vivo [J].
Cherrington, AD ;
Edgerton, D ;
Sindelar, DK .
DIABETOLOGIA, 1998, 41 (09) :987-996
[10]   C-13-NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY STUDIES OF HEPATIC GLUCOSE-METABOLISM IN NORMAL SUBJECTS AND SUBJECTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
CLINE, GW ;
ROTHMAN, DL ;
MAGNUSSON, I ;
KATZ, LD ;
SHULMAN, GI .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2369-2376